Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...

Published on 24 May 2024 on The Business Journals

Needham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...

Read the rest of the article

Start tracking your investments with Statfolio

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.01%

Investing.com 27 May 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than ...

Benzinga 24 May 2024

Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 ...

Zacks via Yahoo Finance 24 May 2024

Needham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as o...

The Business Journals 24 May 2024

Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy resul...

Benzinga via AOL 24 May 2024

Introduction to the Transaction Andreas Halvorsen (Trades, Portfolio)'s Viking Global Investors L...

GuruFocus.com via Yahoo Finance 15 Feb 2024

On February 6, 2024, Robert Gagnon, a director at Verastem Inc, executed a sale of 9,204 shares o...

GuruFocus.com via Yahoo Finance 7 Feb 2024

Verastem Oncology VSTM announced that the FDA has granted the Fast Track designation to its inves...

Zacks via Yahoo Finance 24 Jan 2024

It's nice to see the Verastem, Inc. (NASDAQ:VSTM) share price up 15% in a week. But will that rep...

Simply Wall St. via Yahoo Finance 2 May 2023

This could be a major catalyst for the company. 9. Galaxy GamingInc (GLXZ) Galaxy Gaming is a cas...

GoBankingRates via AOL 19 Apr 2023